The AI arms race utilization management intensifies payer-provider conflicts, raising risks for hospitals and health systems nationwide.

In a field where an algorithm's decision can determine a patient's access to life-saving medication, "black box" AI is an ...

Clinical accountability remains firmly with human providers when utilizing new diagnostic technology for midlife women's ...

PALI-2108 demonstrated favorable safety and tolerability with no serious adverse events after two weeks of treatment in a difficult-to-treat populationPhase 1b data demonstrate endoscopic improvement ...

The data reveals key market opportunities in enhancing compliance through expertise in PMS, PMCF, and vigilance for digital health technologies. Emphasizing real-world data, risk management, and ...

This article argues for the adoption of a combined lyophilized plasma and platelet product strategy to address critical gaps.

Dry eye disease (DED) has long occupied a somewhat uneasy place in the cataract and refractive surgery workflow. It is ...

As ambient documentation and gen AI spread across clinical workflows, healthcare IT leaders are reassessing governance, ...

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing ...

Absolute Difference in the Cema-Cel Arm Over the Observation Arm Exceeded Clinically Meaningful Benchmark Based on Literature of 25-30%MRD Reduction Occurred Rapidly Following Cema-Cel Treatment with ...

Pharma stocks draw interest as pipelines, clinical trials and acquisitions support growth outlook despite patent expiry ...

Discover eight practical strategies for digital healthcare transformation that improve patient outcomes, streamline provider ...